Expert Analysis: Adaptive Oncology, EMA/FDA/NMPA RbM & Psychedelic MDD
A practical, patient-first analysis of adaptive oncology submissions, global monitoring expectations, pregnancy registries, and psychedelic-assisted MDD trials—focused on clarity for patients and sponsors.
Robert Maxwell
Sep 29, 2025
Breast cancer approvals
Pregnancy safety trials
Diaphragm pacing trials
Psychedelic MDD trials